Improving diagnosis of inherited peripheral neuropathies through gene panel analysis
Jazyk angličtina Země Anglie, Velká Británie Médium electronic
Typ dokumentu časopisecké články
PubMed
27549087
PubMed Central
PMC4994270
DOI
10.1186/s13023-016-0500-5
PII: 10.1186/s13023-016-0500-5
Knihovny.cz E-zdroje
- Klíčová slova
- Charcot-Marie-Tooth, Inherited peripheral neuropathies, Mutation, Phenotype, Targeted gene panel testing,
- MeSH
- Charcotova-Marieova-Toothova nemoc diagnóza genetika MeSH
- cytoplazmatické dyneiny genetika MeSH
- DNA-helikasy MeSH
- genetické testování metody MeSH
- genotyp MeSH
- hereditární motorické a senzitivní neuropatie genetika MeSH
- intracelulární signální peptidy a proteiny genetika MeSH
- konexiny genetika MeSH
- lidé MeSH
- multifunkční enzymy MeSH
- mutace MeSH
- nemoci periferního nervového systému diagnóza genetika MeSH
- protein beta 1 mezerového spoje MeSH
- proteiny buněčného cyklu genetika MeSH
- RNA-helikasy genetika MeSH
- věk při počátku nemoci MeSH
- vysoce účinné nukleotidové sekvenování metody MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- cytoplazmatické dyneiny MeSH
- DNA-helikasy MeSH
- DYNC1H1 protein, human MeSH Prohlížeč
- intracelulární signální peptidy a proteiny MeSH
- konexiny MeSH
- multifunkční enzymy MeSH
- N-myc downstream-regulated gene 1 protein MeSH Prohlížeč
- proteiny buněčného cyklu MeSH
- RNA-helikasy MeSH
- SETX protein, human MeSH Prohlížeč
BACKGROUND: Inherited peripheral neuropathies (IPN) are the most common inherited neurological condition. It represents a highly heterogeneous group, both clinically and genetically. Targeted disease specific gene panel massively parallel sequencing (MPS) seems to be a useful tool in diagnosis of disorders with high genetic heterogeneity. METHODS: In our study, we have designed, validated and updated our own custom gene panel of all known genes associated with IPN. One hundred and ninety-eight patients have been tested so far. Only patients in whom mutations in more common causes or relevant genes have already been excluded were enrolled. Five consecutive panel designs were prepared according to recent literature search, the last one covering ninety-three genes. Each patient was tested only once. All data were evaluated with at least two different pipelines. RESULTS: In summary, causative mutation has been found in fifty-one patients (26 %). The results were inconclusive in thirty-one (16 %) patients. No variants of likely significance to IPN were found in one hundred and sixteen (58 %) patients. CONCLUSION: MPS gene panel enables testing of all known IPN causes at once with high coverage and at an affordable cost making it truly a method of choice also in IPN. Gene panel testing results in several interesting results and findings.
Zobrazit více v PubMed
Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet. 1974;6:98–118. doi: 10.1111/j.1399-0004.1974.tb00638.x. PubMed DOI
Braathen GJ. Genetic epidemiology of Charcot-Marie-Tooth disease. Acta Neurol Scand Suppl. 2012 PubMed
Murphy SM, Laura M, Reilly MM. DNA testing in hereditary neuropathies. Handb Clin Neurol. 2013;115:213–232. doi: 10.1016/B978-0-444-52902-2.00012-6. PubMed DOI
Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133:1–9. doi: 10.1007/s00439-013-1358-4. PubMed DOI PMC
Schabhuttl M, Wieland T, Senderek J, Baets J, Timmerman V, De Jonghe P, Reilly MM, Stieglbauer K, Laich E, Windhager R, et al. Whole-exome sequencing in patients with inherited neuropathies: outcome and challenges. J Neurol. 2014;261:970–982. doi: 10.1007/s00415-014-7289-8. PubMed DOI
Haberlova J, Claeys KG, De Jonghe P, Seeman P. Cranial nerves palsy as an initial feature of an early onset distal hereditary motor neuropathy--a new distal hereditary motor neuropathy phenotype. Neuromuscul Disord. 2009;19:427–428. doi: 10.1016/j.nmd.2009.03.005. PubMed DOI
GALAXY. https://usegalaxy.org/. Accessed 15 Sept 2015.
Annovar. http://www.openbioinformatics.org/annovar/. Accessed 2 Nov 2015
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424. doi: 10.1038/gim.2015.30. PubMed DOI PMC
Optimus primer. http://op.pgx.ca/. Accessed 3 Feb 2016
Latour P, Thauvin-Robinet C, Baudelet-Mery C, Soichot P, Cusin V, Faivre L, Locatelli MC, Mayencon M, Sarcey A, Broussolle E, et al. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet. 2010;86:77–82. doi: 10.1016/j.ajhg.2009.12.005. PubMed DOI PMC
Lassuthova P, Brozkova DS, Krutova M, Neupauerova J, Haberlova J, Mazanec R, Dvorackova N, Goldenberg Z, Seeman P. Mutations in HINT1 are one of the most frequent causes of hereditary neuropathy among Czech patients and neuromyotonia is rather an underdiagnosed symptom. Neurogenetics. 2015;16:43–54. doi: 10.1007/s10048-014-0427-8. PubMed DOI
Brozkova DS, Posadka J, Lassuthova P, Mazanec R, Haberlova J, Siskova D, Sakmaryova I, Neupauerova J, Seeman P. Spectrum and frequencies of mutations in the MFN2 gene and its phenotypical expression in Czech hereditary motor and sensory neuropathy type II patients. Mol Med Rep. 2013 PubMed
Lassuthova P, Mazanec R, Vondracek P, Siskova D, Haberlova J, Sabova J, Seeman P. High frequency of SH3TC2 mutations in Czech HMSN I patients. Clin Genet. 2011;80:334–345. doi: 10.1111/j.1399-0004.2011.01640.x. PubMed DOI
Irobi J, Van den Bergh P, Merlini L, Verellen C, Van Maldergem L, Dierick I, Verpoorten N, Jordanova A, Windpassinger C, De Vriendt E, et al. The phenotype of motor neuropathies associated with BSCL2 mutations is broader than Silver syndrome and distal HMN type V. Brain. 2004;127:2124–2130. doi: 10.1093/brain/awh232. PubMed DOI
Windpassinger C, Auer-Grumbach M, Irobi J, Patel H, Petek E, Horl G, Malli R, Reed JA, Dierick I, Verpoorten N, et al. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet. 2004;36:271–276. doi: 10.1038/ng1313. PubMed DOI
Punetha J, Monges S, Franchi ME, Hoffman EP, Cirak S, Tesi-Rocha C. Exome Sequencing Identifies DYNC1H1 Variant Associated With Vertebral Abnormality and Spinal Muscular Atrophy With Lower Extremity Predominance. Pediatr Neurol. 2015;52:239–244. doi: 10.1016/j.pediatrneurol.2014.09.003. PubMed DOI PMC
Kalaydjieva L, Gresham D, Gooding R, Heather L, Baas F, de Jonge R, Blechschmidt K, Angelicheva D, Chandler D, Worsley P, et al. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am J Hum Genet. 2000;67:47–58. doi: 10.1086/302978. PubMed DOI PMC
Hewamadduma C, McDermott C, Kirby J, Grierson A, Panayi M, Dalton A, Rajabally Y, Shaw P. New pedigrees and novel mutation expand the phenotype of REEP1-associated hereditary spastic paraplegia (HSP) Neurogenetics. 2009;10:105–110. doi: 10.1007/s10048-008-0163-z. PubMed DOI
Hoyer H, Braathen GJ, Busk OL, Holla OL, Svendsen M, Hilmarsen HT, Strand L, Skjelbred CF, Russell MB. Genetic diagnosis of Charcot-Marie-Tooth disease in a population by next-generation sequencing. Biomed Res Int. 2014;2014:210401. doi: 10.1155/2014/210401. PubMed DOI PMC
Lupo V, Garcia-Garcia F, Sancho P, Tello C, Garcia-Romero M, Villarreal L, Alberti A, Sivera R, Dopazo J, Pascual-Pascual SI, et al. Assessment of Targeted Next-Generation Sequencing as a Tool for the Diagnosis of Charcot-Marie-Tooth Disease and Hereditary Motor Neuropathy. J Mol Diagn. 2016;18(2):225–34. PubMed
Fridman V, Bundy B, Reilly MM, Pareyson D, Bacon C, Burns J, Day J, Feely S, Finkel RS, Grider T, et al. CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis. J Neurol Neurosurg Psychiatry. 2015;86:873–878. doi: 10.1136/jnnp-2014-308826. PubMed DOI PMC
Gonzaga-Jauregui C, Zhang F, Towne CF, Batish SD, Lupski JR. GJB1/Connexin 32 whole gene deletions in patients with X-linked Charcot-Marie-Tooth disease. Neurogenetics. 2010;11:465–470. doi: 10.1007/s10048-010-0247-4. PubMed DOI PMC
Rudnik-Schoneborn S, Arning L, Epplen JT, Zerres K. SETX gene mutation in a family diagnosed autosomal dominant proximal spinal muscular atrophy. Neuromuscul Disord. 2012;22:258–262. doi: 10.1016/j.nmd.2011.09.006. PubMed DOI
Blankenberg D, Gordon A, Von Kruster G, Coraor N, Taylor J, Nekrutenko A. Manipultion of FASTQ data with Galaxy. Bioinformatics. 2010;26:1783–1785. doi: 10.1093/bioinformatics/btq281. PubMed DOI PMC
DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43:491–498. doi: 10.1038/ng.806. PubMed DOI PMC
Li H. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078–2079. doi: 10.1093/bioinformatics/btp352. PubMed DOI PMC
Li H. Improving SNP discovery by base alignment quality. Bioinformatics. 2011;27:1157–1158. doi: 10.1093/bioinformatics/btr076. PubMed DOI PMC
Li H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics. 2011;27:2987–2993. doi: 10.1093/bioinformatics/btr509. PubMed DOI PMC
Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv. 2013;1303:3997.
Garrison E, Marth G. Haplotype-based variant detection from short-read sequencing. axXiv. 2012;1207:3907.
Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Mann E, Floeter MK, Bidus K, Drayna D, Oh SJ, et al. Mutant dynactin in motor neuron disease. Nat Genet. 2003;33:455–456. doi: 10.1038/ng1123. PubMed DOI
Soong BW, Huang YH, Tsai PC, Huang CC, Pan HC, Lu YC, Chien HJ, Liu TT, Chang MH, Lin KP, et al. Exome sequencing identifies GNB4 mutations as a cause of dominant intermediate Charcot-Marie-Tooth disease. Am J Hum Genet. 2013;92:422–430. doi: 10.1016/j.ajhg.2013.01.014. PubMed DOI PMC
The genetic landscape of axonal neuropathies in the middle-aged and elderly: Focus on MME
HMSN Lom in 12 Czech patients, with one unusual case due to uniparental isodisomy of chromosome 8